LINC02159

Across TCGA pan-cancer cohorts, LINC02159 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02159 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02159 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02159 expression acts as an unfavorable survival marker, although some lineages such as COAD and LUSC show a favorable association.

COAD, BRCA, and LUSC are the cancer types where LINC02159 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.793	0.579	<.001	92	view →
BRCA	DFS	Quartile	All	0.859	0.935	<.001	61	view →
LUSC	DFS	Median	II,III,IV	0.676	0.506	.002	33	view →
STAD	DFS	Median	III,IV	0.244	0.472	.002	28	view →
LUAD	DFS	Tertile	IV	0.437	0.896	.006	18	view →
KIRP	OS	Median	All	0.897	0.539	.009	17	view →
HNSC	DFS	Quartile	All	0.496	0.265	.004	17	view →
THYM	DFS	Median	II,III,IV	0.563	0.895	.003	16	view →
BLCA	DFS	Quartile	II,III,IV	0.245	0.486	.007	14	view →
ACC	OS	Quartile	III,IV	0.869	0.427	.020	10	view →
SKCM	OS	Median	II,III,IV	0.803	0.866	.024	10	view →
LIHC	OS	Quartile	All	0.413	0.684	.015	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02159–COAD (DFS)

Open the COAD breakdown →